This type of BC is a heterogeneous BC lacking expression of ER, PR, and HER2 amplification, and compared with other types of BC that have a higher risk of both local and distant recurrence (Dent et al., 2007; Lejeune et al., 2023). Here, PGR is linked to breast cancer.